Clinical Trials of Bispecific Antibody MDX-210 in Women with Advanced Breast or Ovarian Cancer that Overexpresses HER-2/neu-Reference-Cited by-同舟云学术

Clinical Trials of Bispecific Antibody MDX-210 in Women with Advanced Breast or Ovarian Cancer that Overexpresses HER-2/neu

Published:1995-10 Issue:5 Volume:4 Page:471-475
ISSN:1061-6128
Container-title:Journal of Hematotherapy
language:en
Short-container-title:Journal of Hematotherapy

Author:

VALONE FRANK H.,KAUFMAN PETER A.,GUYRE PAUL M.,LEWIS LIONEL D.,MEMOLI VINCENT,ERNSTOFF MARC S.,WELLS WENDY,BARTH RICHARD,DEO YASHWANT,FISHER JAN,PHIPPS KATHY,GRAZIANO ROBERT,MEYER LOUISE,MROZEK-ORLOWSKI MARY,WARDWELL KATHLEEN,GUYRE VERONICA,MORLEY THERESA L.,ARVIZU CHRISTINE,WALLACE PAUL,FANGER MICHAEL W.

Publisher

Mary Ann Liebert Inc

Subject

Hematology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.1.1995.4.471

Reference5 articles.

1. Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal antibodies with recombinant c-erbB-2

2. The determination of an immunologically active dose of interferon-gamma in patients with melanoma.

3. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases;Cellular & Molecular Immunology;2024-05-24

2. Generation of bispecific antibodies using chemical conjugation methods;Drug Discovery Today: Technologies;2021-12

3. Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds;Journal of Drug Targeting;2020-06-09

4. Bispecific antibody based therapeutics: Strengths and challenges;Blood Reviews;2018-07

5. Bispecific antibodies: design, therapy, perspectives;Drug Design, Development and Therapy;2018-01